PERSPECTA

News from every angle

← Back to headlines

Amgen Receives EC Marketing Authorization for IMDYLLTRA®

Amgen Inc. (AMGN) has announced that the European Commission (EC) has granted marketing authorization for its drug IMDYLLTRA®.

5 Jun, 22:05 — 5 Jun, 22:05
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual79d ago

Amgen Inc. (AMGN) Announces EC’s Grant of Marketing Authorization for IMDYLLTRA®

Read full article →

Related Stories

Mexico's Inflation Accelerates in Early August

25m ago

Billionaire Ron Baron Makes Significant Investment in Undisclosed Giant

27m ago

Greek Stock Market Closes with Marginal Decline

30m ago

US Economy Expected to Grow Despite Higher Rates; Fed and BoE on Hold

37m ago